Extrahepatic Cholangiocarcinoma Ecca clinical trials

Explore recruiting extrahepatic cholangiocarcinoma ecca clinical trials.

Also recruiting in Europe

Extrahepatic Cholangiocarcinoma Ecca trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The CLEAN-DUCT / TRITICC-3 trial - Phase IIa, prospective, single arm, open label, non-randomized, multi-center pilot study of durvalumab (MEDI4736) + intraductal radiofrequency ablation (ID-RFA) in extrahepatic cholangiocarcinoma

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Extrahepatic Cholangiocarcinoma Ecca trials by city

Extrahepatic Cholangiocarcinoma Ecca in Toronto Extrahepatic Cholangiocarcinoma Ecca in Vancouver Extrahepatic Cholangiocarcinoma Ecca in Montreal Extrahepatic Cholangiocarcinoma Ecca in Calgary Extrahepatic Cholangiocarcinoma Ecca in Edmonton Extrahepatic Cholangiocarcinoma Ecca in Ottawa Extrahepatic Cholangiocarcinoma Ecca in Winnipeg Extrahepatic Cholangiocarcinoma Ecca in Quebec City Extrahepatic Cholangiocarcinoma Ecca in Hamilton Extrahepatic Cholangiocarcinoma Ecca in Kitchener Extrahepatic Cholangiocarcinoma Ecca in London Extrahepatic Cholangiocarcinoma Ecca in Halifax Extrahepatic Cholangiocarcinoma Ecca in New York Extrahepatic Cholangiocarcinoma Ecca in Los Angeles Extrahepatic Cholangiocarcinoma Ecca in Chicago Extrahepatic Cholangiocarcinoma Ecca in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease